C-Path's K. Romero Co-Authors Special Report- Striving for an Integrated Drug-Development Process for Neurodegeneration: the Coalition Against Major Diseases
October 2, 2011
Alzheimer’s and Parkinson’s diseases are the two main neurodegenerative disorders and despite the public health need, drug development for these conditions has been plagued by a high attrition rate in the late phases of evaluation.
Thank you for helping us expand participation in this important work! We rely on people with lived experience of ALS to help ensure research reflects the needs and priorities of the community. Please use the form below to nominate someone whose experiences, perspectives, and interests may make them a strong contributor to an ALS Research Working Group. No scientific or medical background is required.
